Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001783732-20-000002
Filing Date
2020-12-16
Accepted
2020-12-16 10:51:45
Documents
1
Effectiveness Date
2020-12-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 5862
  Complete submission text file 0001783732-20-000002.txt   6925
Mailing Address 203 CRESCENT STREET, BLDG #17, STE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET, BLDG #17, STE 102B WALTHAM MA 02453 919-949-8552
Dianthus Therapeutics, Inc. (Filer) CIK: 0001783732 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-345590 | Film No.: 201391534